Janardan Khandekar to Aged
This is a "connection" page, showing publications Janardan Khandekar has written about Aged.
Connection Strength
0.203
-
Prospective analysis of association between use of statins or other lipid-lowering agents and colorectal cancer risk. Ann Epidemiol. 2012 Jan; 22(1):17-27.
Score: 0.027
-
Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers. Gynecol Oncol. 2021 11; 163(2):220-228.
Score: 0.014
-
Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the United Kingdom Biobank. Am J Trop Med Hyg. 2021 Jun 15; 105(2):368-371.
Score: 0.013
-
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
Score: 0.010
-
Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death. Eur Urol. 2017 05; 71(5):740-747.
Score: 0.010
-
Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit. J Cancer Surviv. 2016 Feb; 10(1):206-19.
Score: 0.009
-
Parietal pleurectomy for malignant pleural effusion. Ann Surg Oncol. 1995 Mar; 2(2):160-4.
Score: 0.009
-
Delayed recurrences in primary fallopian tube carcinoma. South Med J. 1993 Nov; 86(11):1314-5.
Score: 0.008
-
Breast cancer in postmenopausal women after non-melanomatous skin cancer: the Women's Health Initiative observational study. Breast Cancer Res Treat. 2013 Jun; 139(3):821-31.
Score: 0.008
-
Prospective analysis of association between use of statins and melanoma risk in the Women's Health Initiative. Cancer. 2012 Oct 15; 118(20):5124-31.
Score: 0.007
-
Effect of cardiopulmonary bypass on tissue injury markers and endothelial activation during coronary artery bypass graft surgery. J Postgrad Med. 2012 Jan-Mar; 58(1):8-13.
Score: 0.007
-
Changes in performance after implementation of a multifaceted electronic-health-record-based quality improvement system. Med Care. 2011 Feb; 49(2):117-25.
Score: 0.006
-
Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients. Arch Dermatol. 1990 Dec; 126(12):1660.
Score: 0.006
-
Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst. 2007 Oct 17; 99(20):1534-43.
Score: 0.005
-
Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma. Cancer Invest. 2007 Aug; 25(5):366-71.
Score: 0.005
-
Cutaneous melanoma in postmenopausal women after nonmelanoma skin carcinoma: the Women's Health Initiative Observational Study. Cancer. 2006 Feb 01; 106(3):654-63.
Score: 0.005
-
Association of nonmelanoma skin cancer with second malignancy. Cancer. 2004 Jan 01; 100(1):130-8.
Score: 0.004
-
Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA. 2003 Jun 25; 289(24):3243-53.
Score: 0.004
-
Phase II study of cisplatin for metastatic prostatic carcinoma. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1983 Apr; 6(2):203-5.
Score: 0.004
-
Causes and evaluation of tumor-induced hypoglycemia. Arch Surg. 1982 Jul; 117(7):905-8.
Score: 0.004
-
Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study. Cancer Treat Rep. 1982 Feb; 66(2):405-6.
Score: 0.003
-
The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer. J Am Coll Surg. 2001 Jul; 193(1):22-8.
Score: 0.003
-
Phase II evaluation of menogaril in advanced prostate cancer: Eastern Cooperative Oncology Group EST P-A885. Am J Clin Oncol. 2001 Apr; 24(2):150-4.
Score: 0.003
-
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments. Cancer. 1979 Sep; 44(3):824-30.
Score: 0.003
-
Paclitaxel as the initial treatment of multiple myeloma: an Eastern Cooperative Oncology Group Study (E1A93). Am J Clin Oncol. 1998 Dec; 21(6):553-6.
Score: 0.003
-
Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases. Arch Intern Med. 1978 Apr; 138(4):539-41.
Score: 0.003
-
Acute erythroleukemia complicating prolonged chemotherapy for ovarian carcinoma. Arch Intern Med. 1977 Mar; 137(3):355-6.
Score: 0.002
-
A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium. Int J Radiat Oncol Biol Phys. 1996 Mar 01; 34(4):793-802.
Score: 0.002
-
High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Invest New Drugs. 1994; 12(4):299-301.
Score: 0.002
-
Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. J Clin Oncol. 1993 Nov; 11(11):2072-80.
Score: 0.002
-
Current status: evaluation of dietary fat reduction as secondary breast cancer prevention. The Nutrition Adjuvant Study. Prog Clin Biol Res. 1990; 339:201-9.
Score: 0.002
-
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Invest New Drugs. 1989 Jul; 7(2-3):255-60.
Score: 0.001
-
Phase II diaziquone-based chemotherapy trials in patients with anaplastic supratentorial astrocytic neoplasms. J Clin Oncol. 1987 Mar; 5(3):464-71.
Score: 0.001
-
Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council. Cancer. 1985 Sep 15; 56(6):1311-5.
Score: 0.001
-
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
Score: 0.001
-
A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res. 1985 Feb; 45(2):863-71.
Score: 0.001
-
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study. Cancer Treat Rep. 1984 Dec; 68(12):1511-2.
Score: 0.001
-
Phase II study of spirogermanium in advanced breast cancer. Cancer Treat Rep. 1984 Dec; 68(12):1515-6.
Score: 0.001
-
Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients. J Biol Response Mod. 1983; 2(3):251-62.
Score: 0.001
-
Urinary bladder metastases from breast carcinoma. Cancer. 1980 Jul 01; 46(1):229-32.
Score: 0.001
-
Metastatic basal cell carcinoma. J Surg Oncol. 1980; 15(2):171-80.
Score: 0.001